15 May 2024

New Human Technopole Strategic Plan 2024-2028 now online!

Five years since its inception, Human Technopole is now a dynamic institute where researchers from around the world have laid the foundations for unravelling the fundamental mechanisms of life across multiple biological scales – molecules, cells, tissues, organs, organisms, populations – in space and time.

Read more
08 May 2024

Director Marino Zerial elected as a new member of the Leopoldina

The German National Academy of Sciences Leopoldina has elected the Dresden and Italian cell biologist Marino Zerial as one of its members. Currently Director of Human Technopole, he is also one of the founding directors of the Max Planck Institute for Molecular Cell Biology and Genetics (MPI-CBG).

Read more
07 May 2024

Autoimmune encephalitis: ItsME Foundation funds Harschnitz Group

The Harschnitz Group has been awarded a grant from the ItsME Foundation to develop a human pluripotent stem cell (hPSC)-derived brainstem model to understand brainstem encephalitis. The ItsME Foundation was founded in 2019 by Jur Deitmers and has its base in The Netherlands, with the goal to fight Meningitis and Encephalitis.

Read more
02 May 2024

Karthik Ramanadane wins a HFSP fellowship for thyroid studies

For the first time in nearly 20 years, Italy  wins a Fellowship from the Human Frontier Science Program (HFSP): our Karthik Ramanadane, Postdoc in the Coscia Group (Structural Biology), will pursue a challenging project on the molecular mechanisms of the thyroid at Human Technopole.

Read more
29 April 2024

Rare diseases: Telethon-Cariplo funds two research projects at HT

Two research projects from Human Technopole have won the Fondazione Telethon and Cariplo grant to uncover the genetic and molecular mechanisms of acute myeloid leukemia and congenital adrenal hyperplasia. The projects, led by Alice Giustacchini (Group Leader of Genomics) and Emanuele Villa and Nicolò Caporale (Testa Group, Neurogenomics), have been respectively funded with €230,000 and €250,000.

Read more